Case 1:18-cv-00924-CFC-SRF Document 439 Filed 10/21/19 Page 1 of 22 PageID #:
`32479
`
`EXHIBIT 1
`REDACTED
`IN ITS
`ENTIRERTY
`
`

`

`Case 1:18-cv-00924-CFC-SRF Document 439 Filed 10/21/19 Page 2 of 22 PageID #:
`32480
`
`EXHIBIT 2
`
`

`

`Case 1:18-cv-00924-CFC-SRF Document 439 Filed 10/21/19 Page 3 of 22 PageID #:
`32481
`
`

`

`Case 1:18-cv-00924-CFC-SRF Document 439 Filed 10/21/19 Page 4 of 22 PageID #:
`32482
`
`

`

`Case 1:18-cv-00924-CFC-SRF Document 439 Filed 10/21/19 Page 5 of 22 PageID #:
`32483
`
`

`

`Case 1:18-cv-00924-CFC-SRF Document 439 Filed 10/21/19 Page 6 of 22 PageID #:
`32484
`
`

`

`Case 1:18-cv-00924-CFC-SRF Document 439 Filed 10/21/19 Page 7 of 22 PageID #:
`32485
`
`EXHIBIT 3
`
`

`

`Case 1:18-cv-00924-CFC-SRF Document 439 Filed 10/21/19 Page 8 of 22 PageID #:
`32486
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`IN THE UNITED STATES DISTRICT COURT
`
`DISTRICT OF DELAWARE
`
`------------------------------------x
`
`GENENTECH, INC. and CITY OF HOPE,
`
`Plaintiffs and
`
`Counterclaim Defendants,
`
`vs. C.A. No.
`
`AMGEN, INC., 18-924-CFC
`
`Defendant and
`
`Counterclaim Plaintiff.
`
`------------------------------------x
`
`GENENTECH, INC. and CITY OF HOPE,
`
`Plaintiffs and
`
`Counterclaim Defendants,
`
`vs. C.A. No.
`
`SAMSUNG BIOEPIS CO., LTD, 18-1363-CFC
`
`Defendant and
`
`Counterclaim Plaintiff.
`
`-----------------------------------x
`
`VIDEOTAPED DEPOSITION OF
`
`SUSAN H. TANNENBAUM, M.D.
`
`WEDNESDAY, OCTOBER 2, 2019
`
`9:34 A.M.
`
`REPORTED BY: ROBERTA CAIOLA
`
`JOB NO. 3562163
`
`PAGES 1 - 124
`
`Veritext Legal Solutions
`800-826-0277
`
`Page 1
`
`

`

`Case 1:18-cv-00924-CFC-SRF Document 439 Filed 10/21/19 Page 9 of 22 PageID #:
`32487
`
`1 A P P E A R A N C E S:
`2 (Continued):
`
`34
`
`FOR DEFENDANT AND COUNTERCLAIM PLAINTIFF
`5 AMGEN, INC.:
`6 COOLEY LLP
`7 3175 Hanover Street
`8 Palo Alto, California 94304-1130
`9 (654) 843-5994
`10 BY: SUSAN KRUMPLITSCH, ESQ.
`11 skrumplitsch@cooley.com
`12
`13 ALSO PRESENT:
`14 TOM DEVINE, Videographer
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`Page 4
`
`I N D E X
`
`1
`
`23
`
` WITNESS: SUSAN H. TANNENBAUM, M.D.
`4 EXAMINATION BY: MS. KRUMPLITSCH
`5 PAGE: 10
`EXHIBITS
`6
`7 TANNENBAUM DESCRIPTION PAGE
`8 Exhibit 1 Expert Report of Susan 7
`9 Tannenbaum, M.D. on Induced
`10 and Willful Infringement of
`11 the Dosing Patents
`12 Exhibit 2 Corrected Expert Report of 7
`13 Susan Tannenbaum, M.D. on
`14 Induced and Willful
`15 Infringement of the Dosing
`16 Patents
`17 Exhibit 3 Document Bates stamped 31
`18 GNE-HER_000983220
`63
`19 Exhibit 4 '196 Patent
`20 Exhibit 5 Deposition transcript of Dr. 68
`21 Susan Tannenbaum on March 6,
`22 2018 in IPR 2017-00731
`23 Exhibit 6 Press release about the 72
`24 launch of Kanjinti, dated
`25 July 18, 2019
`
`Page 5
`2 (Pages 2 - 5)
`
`1234
`
` Videotaped Deposition of SUSAN H.
`5 TANNENBAUM, M.D., taken by Defendant, held
`6 at the offices of Wilmer Cutler Pickering
`7 Hale & Dorr, 7 World Trade Center, 250
`8 Greenwich Street, New York, New York 10007,
`9 before Roberta Caiola, a Shorthand Reporter
`10 and Notary Public within and for the State
`11 of New York.
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`Page 2
`
`1 A P P E A R A N C E S:
`
`2 3
`
`ATTORNEYS FOR PLAINTIFFS AND COUNTERCLAIM
`4 DEFENDANT GENENTECH, INC.:
`5 WILMER HALE
`6 7 World Trade Center
`7 250 Greenwich Street
`8 New York, New York 10007
`9 BY: ROBERT J. GUNTHER, JR., ESQ.
`10 robert.gunther@wilmerhale.com
`11
`12 - and -
`13 WILMER HALE
`14 1225 17th Street, Suite 2600
`15 Denver, Colorado 80202
`16 (720) 274-3152
`17 BY: NORA PASSAMANECK, ESQ.
`18 RACHAEL MILLION-PEREZ, ESQ.
`19 nora.passamaneck@wilmerhale.com
`20 rachael.million-perez@wilmerhale.com
`21
`22
`23
`24
`25
`
`Page 3
`
`Veritext Legal Solutions
`800-826-0277
`
`

`

`Case 1:18-cv-00924-CFC-SRF Document 439 Filed 10/21/19 Page 10 of 22 PageID
`#: 32488
`
`1 EXHIBITS
`2 TANNENBAUM DESCRIPTION PAGE
`3 Exhibit 7 Document Bates stamped 94
`4 GNE-HER_002995913 to
`5 GNE-HER_002995963
`6 Exhibit 8 Document entitled "NCCN 102
`7 Clinical Practice Guidelines
`8 In Oncology Breast Cancer
`9 Version 3.2019 September 6,
`10 2019"
`11 (Exhibits retained by the Court Reporter to
`12 accompany the transcript.)
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`Page 6
`
`1 video recorded deposition of Dr. 09:34:02
`2 Susan Tannenbaum, taken by counsel 09:34:06
`3 for the defendant, in the matter of 09:34:07
`4 Genentech, Inc. v. Amgen, Inc., filed 09:34:10
`5 in the U.S. District Court, District 09:34:12
`6 of Delaware, Civil Action No. 09:34:14
`7 18-924-CFC. 09:34:24
`8 This deposition is being held 09:34:27
`9 at the offices of WilmerHale located 09:34:28
`10 at 7 World Trade Center, New York, 09:34:31
`11 New York. My name is Thomas Devine 09:34:35
`12 from Epiq Reporting, a Veritext 09:34:37
`13 Company, and I am the videographer. 09:34:40
`14 The court reporter is Roberta Caiola, 09:34:41
`15 also with Epiq Reporting, a Veritext 09:34:43
`16 Company. 09:34:46
`17 I am not authorized to 09:34:47
`18 administer an oath. I am not related 09:34:49
`19 to any party in this action, nor am I 09:34:51
`20 financially interested in the 09:34:53
`21 outcome. 09:34:55
`22 Counsel and all present in the 09:34:55
`23 room will now please state their 09:34:56
`24 appearances and affiliations for the 09:34:58
`25 record. 09:35:01
`
`Page 8
`
`1 (Tannenbaum Exhibit 1, Expert 09:25:59
`2 Report of Susan Tannenbaum, M.D. on 09:25:59
`3 Induced and Willful Infringement of 09:25:59
`4 the Dosing Patents, marked for 09:25:59
`5 identification.) 09:25:59
`6 (Tannenbaum Exhibit 2, 09:25:59
`7 Corrected Expert Report of Susan 09:25:59
`8 Tannenbaum, M.D. on Induced and 09:25:59
`9 Willful Infringement of the Dosing 09:25:59
`10 Patents, marked for identification.) 09:33:21
`11 THE VIDEOGRAPHER: Good 09:33:21
`12 morning. We are going on the record 09:33:32
`13 at 9:34 a m., on October 2, 2019. 09:33:34
`14 Please note that the microphones are 09:33:39
`15 sensitive and may pick up whispering, 09:33:41
`16 private conversations, and cellular 09:33:44
`17 interference. 09:33:46
`18 Please turn off all cell phones 09:33:47
`19 or place them away from the 09:33:49
`20 microphones, as they can interfere 09:33:51
`21 with the deposition audio. Audio and 09:33:52
`22 video recording will continue to take 09:33:54
`23 place, unless all parties agree to go 09:33:57
`24 off the record. 09:33:59
`25 This is media unit 1 of the 09:34:00
`
`Page 7
`
`1 If there are any objections to 09:35:01
`2 proceeding please state them at the 09:35:04
`3 time of your appearance, beginning 09:35:05
`4 with noticing attorney. 09:35:06
`5 MS. KRUMPLITSCH: Susan 09:35:06
`6 Krumplitsch of Cooley, representing 09:35:08
`7 Amgen. 09:35:11
`8 MR. GUNTHER: Bob Gunther from 09:35:13
`9 the WilmerHale firm representing 09:35:15
`10 Genentech and the witness. 09:35:16
`11 MS. MILLION-PEREZ: Rachael 09:35:17
`12 Million-Perez from WilmerHale on 09:35:15
`13 behalf of Genentech and the witness. 09:35:14
`14 MS. PASSAMANECK: And also Nora 09:35:22
`15 Passamaneck from WilmerHale for 09:35:24
`16 Genentech, and the witness as well. 09:35:25
`17 THE VIDEOGRAPHER: Thank you. 09:35:26
`18 Roberta, would you please swear 09:35:27
`19 in the witness, after which you may 09:35:28
`20 proceed. 09:35:31
`21 SUSAN H. TANNENBAUM, M.D., called as a
`22 witness, having been first duly sworn by a
`23 Notary Public of the State of New York,
`24 testifies as follows:
`25
`
`Page 9
`3 (Pages 6 - 9)
`
`Veritext Legal Solutions
`800-826-0277
`
`

`

`Case 1:18-cv-00924-CFC-SRF Document 439 Filed 10/21/19 Page 11 of 22 PageID
`#: 32489
`
`

`

`Case 1:18-cv-00924-CFC-SRF Document 439 Filed 10/21/19 Page 12 of 22 PageID
`#: 32490
`
`

`

`Case 1:18-cv-00924-CFC-SRF Document 439 Filed 10/21/19 Page 13 of 22 PageID
`#: 32491
`
`

`

`Case 1:18-cv-00924-CFC-SRF Document 439 Filed 10/21/19 Page 14 of 22 PageID
`#: 32492
`VERITEXT LEGAL SOLUTIONS
`COMPANY CERTIFICATE AND DISCLOSURE STATEMENT
`Veritext Legal Solutions represents that the
`foregoing transcript is a true, correct and complete
`transcript of the colloquies, questions and answers
`as submitted by the court reporter. Veritext Legal
`Solutions further represents that the attached
`exhibits, if any, are true, correct and complete
`documents as submitted by the court reporter and/or
`attorneys in relation to this deposition and that
`the documents were processed in accordance with
`our litigation support and production standards.
`Veritext Legal Solutions is committed to maintaining
`the confidentiality of client and witness information,
`in accordance with the regulations promulgated under
`the Health Insurance Portability and Accountability
`Act (HIPAA), as amended with respect to protected
`health information and the Gramm-Leach-Bliley Act, as
`amended, with respect to Personally Identifiable
`Information (PII). Physical transcripts and exhibits
`are managed under strict facility and personnel access
`controls. Electronic files of documents are stored
`in encrypted form and are transmitted in an encrypted
`fashion to authenticated parties who are permitted to
`access the material. Our data is hosted in a Tier 4
`SSAE 16 certified facility.
`Veritext Legal Solutions complies with all federal and
`State regulations with respect to the provision of
`court reporting services, and maintains its neutrality
`and independence regardless of relationship or the
`financial outcome of any litigation. Veritext requires
`adherence to the foregoing professional and ethical
`standards from all of its subcontractors in their
`independent contractor agreements.
`Inquiries about Veritext Legal Solutions'
`confidentiality and security policies and practices
`should be directed to Veritext's Client Services
`Associates indicated on the cover of this document or
`at www.veritext.com.
`
`

`

`Case 1:18-cv-00924-CFC-SRF Document 439 Filed 10/21/19 Page 15 of 22 PageID
`#: 32493
`
`EXHIBIT 4
`REDACTED
`IN ITS
`ENTIRETY
`
`

`

`Case 1:18-cv-00924-CFC-SRF Document 439 Filed 10/21/19 Page 16 of 22 PageID
`#: 32494
`
`EXHIBIT 5
`REDACTED
`IN ITS
`ENTIRETY
`
`

`

`Case 1:18-cv-00924-CFC-SRF Document 439 Filed 10/21/19 Page 17 of 22 PageID
`#: 32495
`
`EXHIBIT 6
`REDACTED
`IN ITS
`ENTIRETY
`
`

`

`Case 1:18-cv-00924-CFC-SRF Document 439 Filed 10/21/19 Page 18 of 22 PageID
`#: 32496
`
`(cid:40)(cid:59)(cid:43)(cid:44)(cid:37)(cid:44)(cid:55) (cid:26)
`
`

`

`Case 1:18-cv-00924-CFC-SRF Document 439 Filed 10/21/19 Page 19 of 22 PageID
`#: 32497
`
`

`

`Case 1:18-cv-00924-CFC-SRF Document 439 Filed 10/21/19 Page 20 of 22 PageID
`#: 32498
`
`

`

`Case 1:18-cv-00924-CFC-SRF Document 439 Filed 10/21/19 Page 21 of 22 PageID
`#: 32499
`
`

`

`Case 1:18-cv-00924-CFC-SRF Document 439 Filed 10/21/19 Page 22 of 22 PageID
`#: 32500
`
`